Faculty profile
Christopher Rudd
Back to facultyThis profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses and email address may be missing. Find their university profile.
Latest papers
Modulation of polycaprolactone composite properties through incorporation of mixed phosphate glass formulations.
Acta biomaterialia · 2010
Latest funding
- $4,885,389
T-cell signaling and cancer immunotherapy
CIHR · 2017 · Nominated PI
- $204,000
Role of ACK1 (activated Cdc42-associated kinase 1) in adaptor SLP-76 signalling in T-cells
NSERC · 2017 · Principal investigator
1 publications.
Modulation of polycaprolactone composite properties through incorporation of mixed phosphate glass formulations.
Shah Mohammadi M, Ahmed I, Marelli B, Rudd C, Bureau MN, Nazhat SN
T-cell signaling and cancer immunotherapy
Principal investigators: Rudd, Christopher E
Keywords: Cancer; Immune Responses; Immunology; Receptors; Signal Transduction; T-Cells
Role of ACK1 (activated Cdc42-associated kinase 1) in adaptor SLP-76 signalling in T-cells
Principal investigators: Rudd, Christopher
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.